NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer

被引：90

作者：

Berliner, Janice L. ^{[1
]}

Fay, Angela Musial ^{[2
]}

Cummings, Shelly A. ^{[3
]}

Burnett, Brittany ^{[4
]}

Tillmanns, Todd ^{[5
,6
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Basking Ridge, NJ USA

[2] Meridian Hlth, Neptune, NJ USA

[3] Myriad Genet Labs Inc, Salt Lake City, UT USA

[4] Sharp Healthcare, San Diego, CA USA

[5] West Clin, Memphis, TN USA

[6] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA

来源：

JOURNAL OF GENETIC COUNSELING | 2013年 / 22卷 / 02期

关键词：

Hereditary breast and ovarian cancer; BRCA1; BRCA2; Cancer genetic counseling; Risk assessment; Medical management; BRCA2; MUTATIONS; FOUNDER MUTATION; PROSTATE-CANCER; FAMILY-HISTORY; WOMEN; MODEL; SUSCEPTIBILITY; SOCIETY;

D O I：

10.1007/s10897-012-9547-1

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The purpose of this document is to present a current and comprehensive set of practice recommendations for effective genetic cancer risk assessment, counseling and testing for hereditary breast and ovarian cancer. The intended audience is genetic counselors and other health professionals who care for individuals with, or at increased risk of, hereditary breast and/or ovarian cancer.

引用

页码：155 / 163

页数：9

共 53 条

[1] Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2 [J].

Alter, Blanche P. ;

Rosenberg, Philip S. ;

Brody, Lawrence C. .

JOURNAL OF MEDICAL GENETICS, 2007, 44 (01) :1-9

[2]

[Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4

[3] Hereditary Breast and Ovarian Cancer Syndrome [J].

不详 .

GYNECOLOGIC ONCOLOGY, 2009, 113 (01) :6-11

[4]

[Anonymous], 2007, GYNECOL ONCOL, V107, P159

[5] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].

Antoniou, A ;

Pharoah, PDP ;

Narod, S ;

Risch, HA ;

Eyfjord, JE ;

Hopper, JL ;

Loman, N ;

Olsson, H ;

Johannsson, O ;

Borg, Å ;

Pasini, B ;

Radice, P ;

Manoukian, S ;

Eccles, DM ;

Tang, N ;

Olah, E ;

Anton-Culver, H ;

Warner, E ;

Lubinski, J ;

Gronwald, J ;

Gorski, B ;

Tulinius, H ;

Thorlacius, S ;

Eerola, H ;

Nevanlinna, H ;

Syrjäkoski, K ;

Kallioniemi, OP ;

Thompson, D ;

Evans, C ;

Peto, J ;

Lalloo, F ;

Evans, DG ;

Easton, DF .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130

[6] A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes [J].

Antoniou, AC ;

Pharoah, PDP ;

McMullan, G ;

Day, NE ;

Stratton, MR ;

Peto, J ;

Ponder, BJ ;

Easton, DF .

BRITISH JOURNAL OF CANCER, 2002, 86 (01) :76-83

[7] The BOADICEA model of genetic susceptibility to breast and ovarian cancer [J].

Antoniou, AC ;

Pharoah, PPD ;

Smith, P ;

Easton, DF .

BRITISH JOURNAL OF CANCER, 2004, 91 (08) :1580-1590

[8] Assessing the risk of breast cancer. [J].

Armstrong, K ;

Eisen, A ;

Weber, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :564-571

[9] Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer [J].

Atchley, Deann P. ;

Albarracin, Constance T. ;

Lopez, Adriana ;

Valero, Vicente ;

Amos, Christopher I. ;

Gonzalez-Angulo, Ana Maria ;

Hortobagyi, Gabriel N. ;

Arun, Banu K. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4282-4288

[10]

Begg C. B., 2009, JAMA-J AM MED ASSOC, V299, P194

← 1 2 3 4 5 6 →